Over the past several months, I’ve found myself deep in the literature of some of the world’s most remarkable longitudinal studies. Like most of us in clinical research, I was initially drawn to their findings. But the more I read, the more I became fascinated by something else entirely: their…

Pancreatic cancer remains one of the most difficult malignancies to diagnose and treat, largely because early-stage disease is often asymptomatic. Despite decades of research, outcomes for patients with metastatic pancreatic ductal adenocarcinoma have remained poor, with limited treatment options available after first-line therapy fails. Current imaging modalities frequently fail to…

The traditional clinical trial model characterized by discrete phases, manual data entry, and the long “hiatus” between database lock and regulatory review is officially entering the archives. On April 28, 2026, the FDA unveiled a landmark initiative to implement Real-Time Clinical Trials (RTCT), moving the industry toward a model of…